Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 6Carcinoma, Hepatocellular 2Carcinoid Tumor 2Serotonin Syndrome 1Peritoneal Neoplasms 1Neuroendocrine Tumour With Carcinoid Symptoms 1Neoplastic Cells, Circulating 1Neoplasms 1Intestinal Obstruction 1Gastro-enteropancreatic neuroendocrine tumor 1Flushing 1Endocrine Tumors 1Diarrhea 1Carcinoma, Merkel Cell 1Carcinoma 1Acromegaly 1

Interventions

Blood Specimen Collection 13Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Surgical Procedures, Operative 3Pirinitramide 2Morphine 2Bevacizumab 2ribociclib 1lanreotide 1jinfukang 1eribulin 1cabazitaxel 1Zoledronic Acid 1Vinorelbine 1Trastuzumab 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Standard of Care 1Spinal Puncture 1Sorafenib 1Radiofrequency Ablation 1Propofol 1Pemetrexed 1Octreotide 1Letrozole 1Lapatinib 1Injections, Epidural 1Injections 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplastic Cells, Circulating × lanreotide × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡